<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03838536</url>
  </required_header>
  <id_info>
    <org_study_id>18-2216</org_study_id>
    <nct_id>NCT03838536</nct_id>
  </id_info>
  <brief_title>Synergistic Activity of Human Milk Nutrients and Infant Cognition</brief_title>
  <acronym>ICAN</acronym>
  <official_title>Synergistic Activity of Choline, Lutein, and Docosahexaenoic Acid in Human Milk in Support of Cognitive Development: An Egg Intervention Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Egg Nutrition Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To establish a whole food, egg, as a viable study material to supplement mothers and
      infants with nutrients that support optimal brain development. There will be 84 breastfeeding
      dyads, 3 months postnatal.

      Mothers will be randomized to a whole egg or egg white (due to lack of an appropriate control
      food). Initial diet intake will be screened using the NCI's ASA24 24h Dietary Assessment
      Tool. Participants will come to the lab 4 times across 3 months (enrollment, 3 months, 4.5
      months, and 6 months). Milk, saliva, and plasma will be collected from the mother, while
      saliva and plasma (heel stick) are collected from the infant. Diet data will be collected at
      each visit. The infant will complete a recognition memory test using electrophysiology at 6
      months as well as the Bayley Scales of Infant Development at 4.5 months. The mother will
      complete a temperament questionnaire at 3 months and 6 months.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Suspended with COVID-9 pandemic; will resume post-pandemic.
  </why_stopped>
  <start_date type="Actual">February 5, 2019</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">February 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to whole egg or egg white powder to consume throughout the study.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The participants will be given a jar of egg powder without labeling and they will not be aware of which they receive (egg white or whole egg).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recognition Memory in an Oddball Task</measure>
    <time_frame>6 minutes</time_frame>
    <description>The difference in microvolts between the negative deflection to novel pictures and the negative deflection to familiar pictures at approximately 100-400ms after the pictures come on the screen will be measured in an event-related potentials (ERP) paradigm. The investigators hypothesize that the whole egg group will have better memory for the familiar pictures than the egg white group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Breastfeeding, Exclusive</condition>
  <arm_group>
    <arm_group_label>Whole egg powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants are given whole egg powder which contains high levels of the nutrients choline, lutein, and docosahexaenoic acid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Egg white powder</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The participants are given an egg white powder that does not contain the target nutrients (choline, lutein, and docosahexaenoic acid).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whole Egg Powder</intervention_name>
    <description>Breastfeeding mothers will consume the equivalent of 5 whole eggs per week for 3 months.</description>
    <arm_group_label>Whole egg powder</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Egg White Powder</intervention_name>
    <description>Breastfeeding mothers will consume the equivalent of 5 egg whites per week for 3 months.</description>
    <arm_group_label>Egg white powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infant is 12-15 weeks of age at enrollment

          -  healthy, lactating mother age 18-35

          -  gave birth at &gt;38 weeks gestation without remarkable incident

          -  consuming &lt;=50% of the recommended amounts of 2 of the 3, DHA, choline, and lutein

        Exclusion Criteria:

          -  infant with diagnosis or documented suspicion of developmental delay

          -  BMI&gt;29.9 in mother

          -  egg allergy or family history of egg allergy

          -  gestational diabetes

          -  any documented seizure activity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol L Cheatham, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor, University of North Carolina-Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nutrition Research Institute</name>
      <address>
        <city>Kannapolis</city>
        <state>North Carolina</state>
        <zip>28081</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 5, 2019</study_first_submitted>
  <study_first_submitted_qc>February 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breastfeeding</keyword>
  <keyword>Eggs</keyword>
  <keyword>Baby</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

